Table 2. Comparison of non-viral and viral systems in protein expression.
| Non-viral |
Viral |
|||
|---|---|---|---|---|
| Liposome | Molecular conjugate | γ-retrovirus | Lentivirus | |
| Genome | DNA plus lipid | DNA plus polypeptide | ssRNA (7–20 kb) | ssRNA (9 kb) |
| Packaging capacity | >10 kb | >10 kb | 6–10 kb | 8–9 kb |
| Transduction | Dividing/non-dividing cells | Dividing/non-dividing cells | Dividing cells | Dividing/non-dividing cells |
| Transduction efficiency | Low | Low | Moderate | Moderate |
| Expression | Transient | Transient | Stable | Stable |
| Integration | No | No | Integrating | Integrating |
| Biosafety level | BSL-1 | BSL-1 | BSL-2 | BSL-2 |
| Immunogenicity | Low | Low | Moderate–high | Moderate–high |
| Gene therapy strategy | Ex vivo | Ex vivo | Ex vivo | Ex vivo |